|
Scientific and Medical Research Collaboration
R & D STHS carries
out basic scientific research and clinical collaborations with
various scientific and medical Institutions worldwide.
FDA-NCTR:
Together with researchers at the FDA/NCTR center in Little Rock,
Arkansas, USA and SigmaTau HealthScience Pomezia, Italy is carrying
out a joint project to examine mechanism(s) of toxicity and role of
carnitines and other metabolic compounds for their potential benefit
in various diseases states, especially neurodegenerative diseases
and neurotoxicity due to substances of abuse such as methamphetamine
and cocaine. This research applies the latest gene arrays such as
the cDNA array, as well as neurobehavioral, neurophysiological and
neurochemical approaches. The mitochondria and the metabolic systems
are the main targets for these studies and further techniques e.g.
electrophysiological and confocal microscopy techniques will also be
used in this project.
University of South
Carolina, Charleston - USA:
Research collaboration with Professor Naren Banik, Department of
Neurology, Medical University of South Carolina, Charleston, SC is
being established. The role of carnitines in the neurone
regeneration process, in particular spinal cord regeneration
following trauma, is being studied.
Istituto Superiore di Sanità, Dept.
Cell Biology &
Neuroscience, Rome -ITALY:
Together with Dr. Giovanni Laviola and Dr Ronald Herning (NIDA) we
have a NIDA, NIH sponsored project into the neurobehavioral as well
as neurotoxicity problems associated with the abuse of
Methamphetamine and other drugs.
University of Roma,
La Sapienza, Rome - Italy:
Research collaboration with Dr Luciano Saso and his colleagues on
neurotoxicity studies to find protective agents against various
neurotoxic agents, in particular on toxicity of amyloidal peptides
and other potential harmful agents to the CNS.
University of
Cagliari, Cagliari - Italy:
Together with Prof Rino Mancinelli's group at the Department of
Applied Sciences to Biosystems, Section of Human Physiology and
Nutrition, University of Cagliari, the muscular bioenergetic
mechanisms are being studied.
University of
Padova, Padova - Italy:
Together with Prof. DiLisa we have in vitro research studies on the
effects of Carnitines on apoptosis and on the damages induced by UV
radiation, burns or toxic substances.
Free University and Humboldt-University, Berlin – Germany:
Together with Prof. David Groneberg we have a research collaboration
to find effective protective strategies for the pulmonary system and
agents to aid function and enhance respiratory efficiency in disease
states.
University of
Pisa, Pisa – Italy:
Together with Prof Francesco Fornai we are examining factors leading
to mitochondrial dysfunction and other causes of behavioral
impairment. I n particular we are examining agents in a new model of
Parkinson's disease.
IBMC,
Neurobehavior Unit, Porto - Portugal:
Together with Dr Teresa Summavielle with are looking at the action
of Carnitines in MDMA neurotoxicity.
Institute of
Surgical Sciences, University Hospital, Uppsala University Sweden.
Together with Prof Hari Shanker Sharma we are examining strategies
for Neuroprotection and Neuroregeneration.
National
Institute on Drug Abuse (NIDA, NIH), Molecular Neuropsychiatry
Branch, Baltimore – USA:
Together with Dr Ronald Herning and Dr Giovani Laviola (ISS, Rome,
Italy), Prof Ashraf Virmani (Scientific and Clinical, R & D, STHS)
has an official NIDA sponsored project into the role of metabolism
in drug addiction (Methamphetamine, cocaine, MDMA, igobaine). In
particular, the neurobehavioural and CNS changes related to drug
abuse.
Research
Publications ->

|